Literature DB >> 1092299

Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases.

M Talpaert, F Campagnari, L Clerici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1092299     DOI： 10.1016/s0006-291x(75)80047-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  16 in total

1.  Influence of DNA template choice on transcription and inhibition of Escherichia coli RNA polymerase.

Authors:  Joerg Haupenthal; Kristina Hüsecken; Matthias Negri; Christine K Maurer; Rolf W Hartmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site.

Authors:  Audrey Tupin; Maxime Gualtieri; Jean-Paul Leonetti; Konstantin Brodolin
Journal:  EMBO J       Date:  2010-06-18       Impact factor: 11.598

3.  Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycin.

Authors:  Maxime Gualtieri; Philippe Villain-Guillot; Jaqueline Latouche; Jean-Paul Leonetti; Lionel Bastide
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.

Authors:  James A Karlowsky; Nancy M Laing; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

5.  Ribonucleic acid synthesis dependent on exogenous triphosphates in nystatin-treated cells of of Kluyveromyces latis.

Authors:  G Badaracco; G Cassani
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

Review 6.  Platforms for antibiotic discovery.

Authors:  Kim Lewis
Journal:  Nat Rev Drug Discov       Date:  2013-05       Impact factor: 84.694

7.  New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent.

Authors:  Weixing Zhu; Jörg Haupenthal; Matthias Groh; Michelle Fountain; Rolf W Hartmann
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

8.  Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile.

Authors:  Farah Babakhani; Abraham Gomez; Nikki Robert; Pamela Sears
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

9.  Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis.

Authors:  A L Sonenshein; H B Alexander; D M Rothstein; S H Fisher
Journal:  J Bacteriol       Date:  1977-10       Impact factor: 3.490

10.  In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.

Authors:  Philippe Villain-Guillot; Maxime Gualtieri; Lionel Bastide; Jean-Paul Leonetti
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.